{
    "pubmed_id": 35704428,
    "study_identifier": "PMID35704428_study-01",
    "study_name": "Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants",
    "publication_title": "Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants",
    "study_objective": "To characterize infection-induced immunity and vaccine-induced immunity against newly emerged omicron subvariants.",
    "study_description": "Emerging subvariants of the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have reignited concern about further immune escape. Specifically, BA.2.12.1, which is on the rise in the United States, has two more mutations (L452Q and S704L) than BA.2 (Fig. S1A in the Supplementary Appendix, available with the full text of this letter at NEJM.org). In addition, BA.4 and BA.5 (hereafter, BA.4/5), which bear identical spike proteins, have become the dominant strains in South Africa. Here, we examine neutralizing-antibody titers in serum samples obtained from vaccinated persons who had received a single booster dose of the same vaccine used in the two-dose series and who had been previously infected with SARS-CoV-2.",
    "primary_institution_name": "Ohio State University",
    "study_personnel": [
        {
            "personnel_id": "PMID35704428_personnel-01",
            "honorific": "",
            "last_name": "Oltz",
            "first_name": "Eugene",
            "suffixes": "",
            "organization": "Ohio State University",
            "orchid_id": "",
            "email": "eugene.oltz@osumc.edu",
            "seronet_title_in_study": "Seronet Principal Investigator",
            "role_in_study": "Investigator",
            "site_name": "Ohio State University"
        },
        {
            "personnel_id": "PMID35704428_personnel-02",
            "honorific": "",
            "last_name": "Saif",
            "first_name": "Lind",
            "suffixes": "",
            "organization": "Ohio State University",
            "orchid_id": "",
            "email": "saif.2@OSU.EDU",
            "seronet_title_in_study": "Seronet Investigator",
            "role_in_study": "Investigator",
            "site_name": "data supporting SeroNet publication"
        },
        {
            "personnel_id": "PMID35704428_personnel-03",
            "honorific": "",
            "last_name": "Liu",
            "first_name": "Shan-Lu",
            "suffixes": "",
            "organization": "Ohio State University",
            "orchid_id": "",
            "email": "liu.6244@osu.edu.",
            "seronet_title_in_study": "Seronet Investigator",
            "role_in_study": "Corresponding Author",
            "site_name": "Ohio State University"
        }
    ],
    "study_file": [
        {
            "study_file_name": "PMID35704428_nejmc2206725_appendix.pdf",
            "study_file_description": "Supplementary methods for Pseudovirus Neutralization Assays",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "PMID35704428_data.xlsx",
            "study_file_description": "Subject level Pseudovirus Neutralization Assays data supporting figures in the publication",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "PMID35704428_v1.2.4.xlsm",
            "study_file_description": "Completed curation of the study into SeroNet Registry Template which includes SeroNet Study Descriptors",
            "study_file_type": "Study Summary Description"
        },
        {
            "study_file_name": "PMID35704428_JSON.json",
            "study_file_description": "JSON format of completed curation of the study into SeroNet Registry Template which includes SeroNet Study Descriptors",
            "study_file_type": "\u200bJSON\u00a0Summary Description"
        }
    ],
    "study_link": [],
    "research_focus": "Infection Response",
    "study_type": "Serosurveillance",
    "keyword": [
        "Not provided"
    ],
    "clinical_study_design": "Case-control Study",
    "in_silico_model_type": "Not Applicable",
    "protocol": {
        "protocol_id": "PMID35704428_protocol-01",
        "protocol_file_name": "PMID35704428_protocol-01.txt",
        "protocol_name": "PMID35704428_protocol-01",
        "protocol_description": "Study Protocol",
        "protocol_type": "Study Protocol"
    },
    "reported_health_condition": [
        "Covid-19"
    ],
    "sars_cov_2_vaccine_type": [
        "Johnson & Johnson SARS-CoV-2 vaccine",
        "Moderna SARS-CoV-2 vaccine",
        "Pfizer-BioNTech SARS-CoV-2 vaccine"
    ],
    "clinical_outcome_measure": "Not Applicable",
    "enrollment_start_date": "2021-01-01",
    "enrollment_end_date": "2022-01-03",
    "number_of_study_subjects": 78,
    "age_unit": "Years",
    "minimum_age": 22,
    "maximum_age": 87,
    "study_human_cohort": [
        {
            "arm_id": "PMID35704428_human_subject-01",
            "arm_name": "Health care workers 2 doses vaccin",
            "study_population_description": "Health care workers 2 doses vaccine",
            "arm_type": "Active Comparator Arm",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "US: Ohio"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Uninfected",
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [
                "Moderna COVID-19 vaccine; VO:0005157",
                "Pfizer BioNTech COVID-19 vaccine; VO:0004987"
            ],
            "covid_19_disease_severity": [],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35704428_human_subject-02",
            "arm_name": "Health Care workers 3 doses vaccin",
            "study_population_description": "Health Care workers 3 doses vaccine",
            "arm_type": "Active Comparator Arm",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "US: Ohio"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Uninfected",
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [
                "Moderna COVID-19 vaccine; VO:0005157",
                "Pfizer BioNTech COVID-19 vaccine; VO:0004987"
            ],
            "covid_19_disease_severity": [],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35704428_human_subject-03",
            "arm_name": "Patients in ICU during Delta wave",
            "study_population_description": "Patients in ICU during Delta wave",
            "arm_type": "Active Comparator Arm",
            "ethnicity": [
                "Hispanic or Latino",
                "Not Hispanic or Latino"
            ],
            "race": [
                "Black or African American",
                "White"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "US: Ohio"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [
                "Johnson & Johnson COVID-19 vaccine; VO:0005159",
                "Moderna COVID-19 vaccine; VO:0005157",
                "Pfizer BioNTech COVID-19 vaccine; VO:0004987"
            ],
            "covid_19_disease_severity": [
                "Severe"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35704428_human_subject-04",
            "arm_name": "Hospitalized patients during Omicron wave",
            "study_population_description": "Hospitalized patients during Omicron wave",
            "arm_type": "Active Comparator Arm",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "US: Ohio"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [
                "Moderna COVID-19 vaccine; VO:0005157",
                "Pfizer BioNTech COVID-19 vaccine; VO:0004987"
            ],
            "covid_19_disease_severity": [
                "Severe"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        }
    ],
    "study_model_cohort": [],
    "planned_visit": [
        {
            "visit_id": "PMID35704428_visit-02",
            "visit_name": "Serum collection health care workers post 3rd dose for Recipients of three vaccine doses",
            "visit_order_number": 1,
            "visit_min_start_day": 5,
            "visit_max_start_day": 80,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35704428_visit-01",
            "visit_name": "Serum collection health care workers post 2nd dose for Recipients of two vaccine doses",
            "visit_order_number": 2,
            "visit_min_start_day": 22,
            "visit_max_start_day": 31,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35704428_visit-03",
            "visit_name": "Serum collection Delta-wave ICU patients, post 1st dose for Recipients of one vaccine dose",
            "visit_order_number": 3,
            "visit_min_start_day": 141,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35704428_visit-06",
            "visit_name": "Serum collection Omicron-wave hospitalized patients, post 2nd dose for Recipients of two vaccine doses",
            "visit_order_number": 4,
            "visit_min_start_day": 149,
            "visit_max_start_day": 367,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35704428_visit-07",
            "visit_name": "Serum collection Omicron-wave hospitalized patients, post 3rd dose for Recipients of three vaccine doses",
            "visit_order_number": 5,
            "visit_min_start_day": 213,
            "visit_max_start_day": 550,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35704428_visit-04",
            "visit_name": "Serum collection Delta-wave ICU patients,  post 2nd dose for Recipients of two doses",
            "visit_order_number": 6,
            "visit_min_start_day": 345,
            "visit_max_start_day": 395,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35704428_visit-05",
            "visit_name": "Serum collection Delta-wave ICU patients, post 3rd dose for Recipients of three vaccine doses",
            "visit_order_number": 7,
            "visit_min_start_day": 357,
            "visit_max_start_day": 407,
            "visit_start_rule": ""
        }
    ],
    "experiment": [
        {
            "arm_id": [
                "PMID35704428_human_subject-01, PMID35704428_human_subject-02, PMID35704428_human_subject-03, PMID35704428_human_subject-04"
            ],
            "associated_first_planned_visit_id": [
                "PMID35704428_visit-01, PMID35704428_visit-02, PMID35704428_visit-03, PMID35704428_visit-04, PMID35704428_visit-05, PMID35704428_visit-06, PMID35704428_visit-07"
            ],
            "assay_type": "Pseudovirus Neutralization Assay",
            "experiment_name": "pseudotyped lentivirus neutralization assay",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Serum"
            ],
            "biospecimen_collection_point": [
                "Post-vaccination"
            ],
            "sars_cov_2_antigen": [
                "Full Length Spike Trimer"
            ],
            "assay_use": "Research Use Only",
            "manufacture": "components from multiple manufacturers",
            "catalog_number": "",
            "virus_target": [],
            "antibody_isotype": [
                "Other"
            ],
            "reporting_units": "",
            "assay_reporting_format": ""
        }
    ],
    "geriatric_subjects": "Yes",
    "pediatric_subjects": "No",
    "pregnant_subjects": "No",
    "sars_cov_2_antibodies_measured": "Yes",
    "survey_instrument_shared": "Not Specified",
    "who_disease_severity_scale_used": "Not Specified",
    "inclusion_exclusion": [
        {
            "inclusion_exculusion_id": "PMID35704428_inexcl-01",
            "inclusion_criterion": "Geriatric subjects",
            "inclusion_criterion_category": "inclusion"
        },
        {
            "inclusion_exculusion_id": "PMID35704428_inexcl-02",
            "inclusion_criterion": "Pediatric subjects",
            "inclusion_criterion_category": "exclusion"
        },
        {
            "inclusion_exculusion_id": "PMID35704428_inexcl-03",
            "inclusion_criterion": "Pregnant subjects",
            "inclusion_criterion_category": "exclusion"
        },
        {
            "inclusion_exculusion_id": "PMID35704428_inexcl-04",
            "inclusion_criterion": "SARS-CoV-2 Antibodies Measured",
            "inclusion_criterion_category": "inclusion"
        }
    ],
    "status_note": "Data at individual level available."
}
